Tefowell 300mg Tablet

Tefowell 300mg tablet consists of the active substance called Tenofovir Disoproxil Fumarate, which belongs to the class of antiretroviral or Anti-Viral medicine. This medicine treats HIV (human immunodeficiency virus) and HBV (hepatitis B virus) infections. It is a nucleotide reverse transcriptase inhibitor (NRTI) and works by inhibiting the enzymes (HIV reverse transcriptase; hepatitis B DNA polymerase) that are important for virus replication. It should always take in combination with other medicines to treat HIV infection. This tablet is suitable for the adult and adolescents aged from 12 to 18 years. For HIV, this medicine is given to adolescents who have already been medicated with other HIV medicines which are no longer fully effective due to resistance or have caused side effects. This tablet is not been studied in patients over 65 years of age. Do not consume this drug if you have experienced hypersensitivity reactions to Tenofovir disoproxil fumarate or any of its ingredients. During the Tefowell 300mg tablet tablet treatment, your doctor may periodically monitor your blood counts, bone mineral density, liver and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure, pancreatitis, bone disease (osteonecrosis - the death of bone tissue), fractures, liver (chronic hepatitis B or C), or kidney problems. Tefowell 300mg tablet should not be given to adolescents with existing kidney problems. If you have lactose intolerance, notify your doctor before starting the treatment. Inform your doctor if you planning to get pregnant, or pregnant, or think you may be pregnant. Breastfeeding is not recommended due to the potential transmission of HIV. Use effective contraception to avoid transmission of HIV infection from patients.